3-(2-氯苯基)丙酸乙酯 | 30573-88-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(2-氯苯基)丙酸乙酯
• 中文别名: 3-氯苯丙酸乙酯；2-氯苯丙酸乙酯
• 英文名称: ethyl 3-(2-chlorophenyl)propanoate
• CAS: 30573-88-7
• 化学式: C₁₁H₁₃ClO₂
• mdl: MFCD09028798
• 分子量: 212.676
• InChiKey: PRDDIJZMYPKFOA-UHFFFAOYSA-N

物化性质

• 沸点：
  150 °C(Press: 12 Torr)
• 密度：
  1.136±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2916399090
• 危险性防范说明：
  P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P362,P403+P233,P501
• 危险性描述：
  H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Ethyl 3-(2-chlorophenyl)propanoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl 3-(2-chlorophenyl)propanoate
CAS number: 30573-88-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H13ClO2
Molecular weight: 212.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(2-氯苯基)丙酸乙酯 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 生成 3-(2-氯苯基)-1-丙醇
  参考文献：
  名称：

  Homocyclic Ring Closures via Benzyne Intermediates. A New Synthesis of 1-Substituted Benzocyclobutenes¹

  摘要：

  DOI：

  10.1021/jo01058a019
• 作为产物：
  描述：

  邻氯肉桂酸 在 platinum(IV) oxide 盐酸 、 氢气 作用下， 以 乙醚 、 乙醇 为溶剂， 生成 3-(2-氯苯基)丙酸乙酯
  参考文献：
  名称：

  Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.

  摘要：

  A series of 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils were synthesized and tested for inhibition of murine liver uridine phosphorylase (UrdPase). Inhibitors of UrdPase are reported to enhance the chemotherapeutic utility of 5-fluoro-2'-deoxyuridine and 5-fluorouracil and to ameliorate zidovudine-induced anemia in animal models. We prepared a series of 5-aryl-substituted analogues of 5-benzylacyclouridine (BAU), a good inhibitor of UrdPase (IC50 of 0.46 mu M), to develop a compound with enhanced potency and improved pharmacokinetics. The first phase of structure-activity relationship studies on a series of 32 aryl-substituted 5-benzyluracils found several 5-(3-alkoxybenzyl) analogues of 5-benzyluracil with enhanced potency. The acyclovir side chain, the (2-hydroxyethoxy)methyl group, was substituted on the more potent aryl-substituted 5-benzyluracils. The two most potent compounds, 10y (3-propoxy) and 10dd (3-sec-butoxy), were inhibitors of UrdPase with IC(50)s of 0.047 and 0.027 mu M, respectively. Six compounds were tested in vivo for effects on steady-state concentrations of circulating uridine in rats. Plasma uridine levels were elevated 3-9-fold by compound levels that ranged from 8 to 50 mu M.

  DOI：

  10.1021/jm00019a015

文献信息

• Highly Enantioselective Synthesis of Atropisomeric Anilide Derivatives through Catalytic Asymmetric N-Arylation:  Conformational Analysis and Application to Asymmetric Enolate Chemistry
  作者：Osamu Kitagawa、Masatoshi Yoshikawa、Hajime Tanabe、Tomofumi Morita、Masashi Takahashi、Yasuo Dobashi、Takeo Taguchi

  DOI：10.1021/ja064026n

  日期：2006.10.1

  enantioselectivity (88-96% ee) to give atropisomeric N-(p-nitrophenyl)anilides having an N-C chiral axis in good yields. Atropisomeric anilide products highly prefer to exist as the E-rotamer which has trans-disposed o-tert-butylphenyl group and carbonyl oxygen. The application of the present catalytic enantioselective N-arylation to an intramolecular version gives atropisomeric lactam derivatives with high

  在 (R)-DTBM-SEGPHOS-Pd(OAc)(2) 催化剂存在下，各种邻叔丁基苯胺与对碘硝基苯的 N-芳基化（芳香胺化）以高对映选择性 (88-96% ee) 进行以良好的产率得到具有 NC 手性轴的阻转异构 N-（对硝基苯基）苯胺。阻转异构苯胺产品更倾向于以具有转位邻叔丁基苯基和羰基氧的 E-旋转异构体形式存在。将本催化对映选择性 N-芳基化应用于分子内形式得到具有高光学纯度 (92-98% ee) 的阻转异构内酰胺衍生物。由阻转异构苯胺和内酰胺产物制备的烯醇锂与各种卤代烷反应得到具有高非对映选择性（非对映异构体比 = 13:1 至 46:1）的 α-烷基化产物。
• Synthese totale de steroides a cycle c aromatique
  作者：C. Berrier、J.P. Gesson、J.C. Jacquesy、A. Renoux

  DOI：10.1016/s0040-4020(01)91335-3

  日期：1984.1

  The ring-C aromatic analogue 4 of 4-androstene 3,17-dione and its 11 hydroxylated (methoxylated) derivatives 20a(b) were prepared by a practical synthetic route. The key steps of the sequence are achieved in superacid: the cyclisation of diarylethane 5a to phenanthrenone 17, and the hydroxylation by hydrogen peroxide of ketone 4 to phenol 20a.

  通过实际的合成方法制备了4-雄烯3，17-二酮的C环芳族类似物4及其11个羟基化（甲氧基化）衍生物20a（b）。该序列的关键步骤是在超酸中实现的：将二芳基乙烷5a环化为菲咯酮17，以及将过氧化氢将酮4羟基化为苯酚20a。
• 4-Pyrimidone compounds
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04145546A1

  公开（公告）日：1979-03-20

  The compounds are substituted isocytosines which are histamine H.sub.2 -antagonists. Two specific compounds of the present invention are 2-\x9b2-(5-methyl-4-imidazolylmethylthio)-ethylamino!-5-(3-methoxybenzyl)-4-p\n' yrimidone and 2-\x9b2-(5-methyl-4-imidazolylmethylthio)ethylamino!-5-benzyloxy-4-pyrimidone\n' .

  这些化合物是取代的异胞嘧啶，是组胺H.sub.2-拮抗剂。本发明的两种特定化合物是2-β2-(5-甲基-4-咪唑基甲硫基)-乙基氨基-5-(3-甲氧基苄基)-4-吡咯啉酮和2-β2-(5-甲基-4-咪唑基甲硫基)乙基氨基-5-苄氧基-4-吡咯啉酮。
• Nicotinamide Derivatives
  申请人：Crawforth James Michael

  公开号：US20110306597A1

  公开（公告）日：2011-12-15

  The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are defined herein, to compositions containing such compounds and to the uses of such compounds for the treatment of allergic and respiratory conditions.

  本发明涉及公式(I)的化合物及其药学上可接受的盐和溶剂，其中取代基在此定义，以及包含这种化合物的组合物，以及这种化合物用于治疗过敏和呼吸系统疾病的用途。
• Forging Medium Rings via I(I)/I(III)‐Catalyzed Diene Carbofunctionalization
  作者：You‐Jie Yu、Joel Häfliger、Zi‐Xuan Wang、Constantin G. Daniliuc、Ryan Gilmour

  DOI：10.1002/anie.202309789

  日期：2023.9.18

  An I(I)/I(III) catalysis-based strategy to access 8-membered carbocycles via the direct carbofunctionalization of 2-phenethyl-substituted 1,3-dienes is disclosed. This strategy to generate densely functionalized, fluorinated benzocyclooctenes is modular and through changes in the oxidation/activation regime and the external nucleophile, the challenging cyclization can be merged with formation of allylic

  公开了一种基于 I(I)/I(III) 催化的策略，通过 2-苯乙基取代的 1,3-二烯的直接碳官能化来获得 8 元碳环。这种生成密集功能化氟化苯并环辛烯的策略是模块化的，通过氧化/活化机制和外部亲核试剂的变化，具有挑战性的环化可以与烯丙基 C−O、C−N 和 C−C 键的形成合并（> 30 个例子）。